South Africa could have been the biggest player in the global cannabis industry – however, a lack of consolidated plans and enforcement to actualise this means the country’s R30 billion masterplan is being left to wither and die.
This is the view presented by the founder and CEO of integrated agricultural and pharmaceutical company Nexus Pharma, Johann Slabber, who is calling for better collaboration between the private and public sectors to get South Africa’s commercial cannabis plans on track.
There have been many legislative developments for cannabis (dagga) in South Africa over recent years, however the regulation for recreational and medicinal cannabis use significantly differs.
In South Africa, private, small-scale recreational cannabis use among adults is permitted, while commercial use is restricted to medicinal and industrial applications under strict regulations.
Read more Here.
